scholarly article | Q13442814 |
P2093 | author name string | Gobel FL | |
Goodwin JF | |||
Hardarson T | |||
Oakley CM | |||
Shah PM | |||
Adelman AG | |||
Wigle ED | |||
Burchell HB | |||
Curiel R | |||
De La Calzada C | |||
P433 | issue | 2 | |
P921 | main subject | hypertrophic obstructive cardiomyopathy | Q55065467 |
P304 | page(s) | suppl II:179-95 | |
P577 | publication date | 1974-08-01 | |
P1433 | published in | Circulation Research | Q2599020 |
P1476 | title | The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy | |
P478 | volume | 35 |
Q67014753 | Hemodynamics and coronary angiography in idiopathic hypertrophic subaortic stenosis |
Q35770817 | Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy |
Q42339402 | Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment |
Q68991974 | Hypertrophic cardiomyopathy, ten years' experience |
Q36492134 | Hypertrophic cardiomyopathy: Prognosis with medical or surgical therapy |
Q39898213 | Idiopathic hypertrophic subaortic stenosis: Evaluation of anginal symptoms with thallium-201 myocardial imaging |
Q58565838 | Interrelationship Between Kidney Function and Percutaneous Mitral Valve Interventions: A Comprehensive Review |
Q33174589 | Left ventricular chamber dilatation in hypertrophic cardiomyopathy: related variables and prognosis in patients with medical and surgical therapy |
Q33171846 | Long-term medical management of hypertrophic obstructive cardiomyopathy |
Q60921259 | Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand |
Q33145751 | Natural history of hypertrophic cardiomyopathy |
Q42680372 | Percutaneous transluminal septal reduction for hypertrophic obstructive cardiomyopathy: report from an international pilot study |
Q40086997 | The frontiers of cardiomyopathy |
Q31934960 | The role of pharmacologic treatment to prevent sudden death in the implantable cardioverter defibrillator era. |
Q47613563 | Women with hypertrophic cardiomyopathy have worse survival. |
Search more.